adverse cardiovascular events - Globe Thesis

Keyword [adverse cardiovascular events] Result: 21 - 40 \| Page: 2 of 10
21.	Study On The Association Between Acute Coronary Syndrome Patients With Stress Hyperglycemia And Adverse Cardiovascular Events During Hospitalization
22.	The Clinical Significance Of ST Segment Changes Of AVR Lead In Patients With Acute Myocardial Infarction
23.	The Prognostic Value Of Impaired Glucose Tolerance In Patients With Coronary Artery Disease Treated With Percutaneous Coronary Intervention
24.	The Impact Of Mild Renal Abnormalities On Prognosis Of Acute Coronary Syndrome With Percutaneous Coronary Intervention
25.	Relationship Of The Clopidogrel Dose, Single Nucleotide Polymorphism,Platelet Aggregation, And Clinical Outcome In Patients Undergoing Percutaneous Coronary Intervention:the RDPAC Study
26.	Association Of Cytochrome P4502C19Polymorphism With Cardiovascular Events In Patients With Coronary Artery Disease After Drug-eluting Stent Implantation
27.	The Influence Of Deceleration Capacity Of Heart Rate And Heart Rate Deceleration Runs On Evaluating Prognosis Of Patients With Acute Myocardial Infarction
28.	The Influence Of Coronary Collateral Circulation On Evaluating Prognosis Of Patients With Emergency Percutaneous Coronary Intervention For Acute Myocardial Infarction
29.	The Relation Between GDF-15,hs-CRP And Major Adverse Cardiovascular Events In ACS Patient
30.	Prognostic Value Of Mean Platelet Volume On Major Adverse Cardiovascular Events In Patients With ST-elevated Myocardial Infarction After Percutaneous Coronary Intervention
31.	The Clinical Intervention Research About Shenhongtongluo Decoction On Coronary Heart Disease Patients After PCI(Qi Deficiency And Blood Stasis, Phlegm Turbidity Of Resistance)
32.	The Predictive Value Of The Plasma BNP To Recent Ventricular Remodeling In Patients With Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention
33.	Effects And Cost-effectiveness Analysis Of Naoxintong Capsule Combined With Dual Antiplatelet Therapy In Patients With CYP2C19 Loss-of-function Gene Mutant After Percutaneous Coronary Intervention
34.	Relationship Between CYP2C19 Polymorphisms With Residual Platelet Reactivity And Prognosis In Clopidogrel-treated Patients After PCI
35.	The Influence Of Different Modes Of Clopidogrel Discontinuation On The Platelet Function In Patients After Percutaneous Coronary Intervention
36.	The Predictive Value Of Neutrophil To Lymphocyte Ratio And Platelet To Lymphocyte Ratio For In-hospital Major Adverse Cardiovascular Events In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
37.	Association Of Cystatin C And Coronary Artery Severity In Patients With Acute Coronary Syndrome And Diabetes Mellitus And Its Correlation With Short-term Prognosis
38.	The Clinical Effects Of Intensive Statin Therapy On Acute Coronary Syndrome With Percutaneous Coronary Intervention
39.	Clinical Study On Treatment Of Fractional Flow Reserve Intervention In Critical Lesions Of Coronary Heart Disease
40.	The Retrospective Study Of The Influence Of Pantoprazole To The Clinical Outcomes Concerned With Adverse Cardiovascular Events And Upper Gastrointestinal Hemorrhage In The CAD Patients After PCI Combined With Clopidogrel
<<First <Prev Next> Last>> Jump to